Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (741-750 of 850) with videos related to

Pageof 85
Sort By:
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
European Urology Open Science|October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive NephrectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Urologic Oncology|September 7, 2025
Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomyCalogero Catanzaro, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Surgical Oncology|June 13, 2025
Cancer-Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non-Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
Journal of Surgical Oncology|July 12, 2026
Open Conversion at Robotic Adrenalectomy: Rates and PredictorsAndrea Marmiroli, Mattia Longoni, Quynh Chi Le, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Pageof 85

Showing results (741-750 of 850) with videos related to

Sort By:
Pageof 85
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
European Urology Open Science|October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive NephrectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Urologic Oncology|September 7, 2025
Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomyCalogero Catanzaro, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Surgical Oncology|June 13, 2025
Cancer-Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non-Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
Journal of Surgical Oncology|July 12, 2026
Open Conversion at Robotic Adrenalectomy: Rates and PredictorsAndrea Marmiroli, Mattia Longoni, Quynh Chi Le, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Pageof 85